CraniUS™, an R&D company focused on groundbreaking diagnostics and treatments for patients with chronic brain disease, has been awarded a competitive $1 million grant from the State of Maryland as part of Governor Wes Moore’s Build Our Future Innovation Infrastructure Pilot Program.

CraniUS LLC, an R&D company focused on groundbreaking diagnostics and treatments for patients with chronic brain diseases, has been honored as Company of the Year - Top MedTech Startup 2023 by MedTech Outlook.

Mike Maglin joined the CraniUS team as CEO in July 2021 after spending 24 years in four different Fortune 1000 companies, serving in several senior leadership capacities.

Mike Maglin joined the CraniUS team as CEO in July 2021 after spending 24 years in four different Fortune 1000 companies, serving in several senior leadership capacities.

CraniUS becomes the first company with a smart, refillable, and fully embedded medical device that effectively bypasses the blood-brain barrier and achieves long-term, convection-enhanced medicine delivery.

CraniUS LLC, an R&D company focused on building breakthrough diagnostics and treatments for neurosurgical patients with chronic brain disease announced a critical partnership with leading FDA-registered drug and device manufacturer, Medical Product Laboratories, Inc (Phila. PA).

CraniUS LLC, an R&D company focused on building groundbreaking diagnostics and treatments for neurosurgical patients with chronic brain disease, announces the appointment of Sharon Wolfington as Vice Chair to its Board of Directors.

The investment will enable CraniUS to scale its product development to facilitate chronic and direct medicine delivery to help effectively treat brain diseases